Stockscreener 앱 받기
2.72
8.48%
-0.252
시간 외 거래:
2.75
0.03
+1.10%
전일 마감가:
$2.972
열려 있는:
$3.13
하루 거래량:
364.74K
Relative Volume:
1.14
시가총액:
$163.18M
수익:
-
순이익/손실:
$-6.78M
주가수익비율:
-0.0637
EPS:
-42.6996
순현금흐름:
$-4.67M
1주 성능:
-45.82%
1개월 성능:
-76.16%
6개월 성능:
-92.08%
1년 성능:
-95.38%
1일 변동 폭
$2.42
$3.2499
1주일 범위
$2.42
$4.868
52주 변동 폭
$2.42
$87.20
Clearmind Medicine Inc Stock (CMND) Company Profile
CMND을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CMND
Clearmind Medicine Inc
|
2.72 | 4.46M | 0 | -6.78M | -4.67M | -42.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Clearmind Medicine Inc 주식(CMND)의 최신 뉴스
Clearmind Medicine announces receipt of Nasdaq minimum bid price notification - MSN
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
Clearmind Medicine's MEAI Spotlighted in Prestigious Review: Leading Experts Affirm Transformative Potential for Alcohol Use Disorder Treatment - The Manila Times
Clearmind Medicine Regains Compliance With Nasdaq's Minimum Stockholders' Equity Requirement - marketscreener.com
Clearmind Medicine Successfully Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement - The Manila Times
Clearmind Medicine regains compliance with Nasdaq listing rule By Investing.com - Investing.com Canada
Clearmind regains compliance with Nasdaq minimum equity rule - Investing.com
Clearmind Medicine Inc. Regains Compliance with Nasdaq Listing Rule on Minimum Stockholders’ Equity - Quiver Quantitative
Clearmind Medicine Successfully Regains Compliance with Nasdaq's Minimum ... | Associated Press | syndication news - Enidnews.com
Clearmind Medicine To Implement 1-for-40 Reverse Stock Split Next Week - Nasdaq
Why Did Clearmind Medicine Shares Plunge 29% After Hours? - Benzinga
Clearmind Medicine to enact 1-for-40 reverse share split; shares down - MSN
Clearmind Medicine to implement 1-for-40 reverse stock split By Investing.com - Investing.com Australia
Clearmind Medicine to implement 1-for-40 reverse stock split - Investing.com
Clearmind Medicine Inc. Announces 1-for-40 Reverse Share Split to Regain Nasdaq Compliance - Quiver Quantitative
Clearmind Medicine Announces 1-for-40 Reverse Share Split - The Manila Times
Clearmind Medicine Announces 1-for-40 Reverse Share Split | Associated Press | syndication news - Enidnews.com
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification - marketscreener.com
Clearmind Medicine Shares Surge After Securing Final Approval for AUD Drug Trial Site - MSN
Clearmind Medicine reports regaining Nasdaq equity compliance after financings - Investing.com
Clearmind Medicine reports regaining Nasdaq equity compliance after financings By Investing.com - Investing.com Australia
Clearmind Medicine Inc. Receives Nasdaq Compliance Notice Regarding Minimum Bid Price Requirement - Quiver Quantitative
Clearmind Medicine stock drops after Nasdaq compliance notice By Investing.com - Investing.com South Africa
Clearmind Medicine stock drops after Nasdaq compliance notice - Investing.com
Is Clearmind Medicine Inc. stock near bottom after declineWeekly Loss Report & High Return Stock Watch Alerts - Newser
Will Clearmind Medicine Inc. stock outperform tech sector in 2025July 2025 Catalysts & Safe Investment Capital Preservation Plans - Newser
How Clearmind Medicine Inc. (CWY0) stock behaves under inflation pressureWeekly Gains Report & Low Risk Entry Point Tips - Newser
Clearmind Medicine Inc files for offering of up to 16 million common sharesSEC filing - marketscreener.com
What MACD trends signal for Clearmind Medicine Inc. (CWY0) stock - Newser
Is Clearmind Medicine Inc. (CWY0) stock a good hedge against inflationJuly 2025 Levels & Risk Managed Investment Signals - Newser
Can Clearmind Medicine Inc. (CWY0) stock double in coming yearsJuly 2025 Earnings & Verified High Yield Trade Plans - Newser
Clearmind enrolls first participant in AUD trial at Hadassah Medical - Investing.com India
Clearmind enrolls first participant in AUD trial at Hadassah Medical By Investing.com - Investing.com Canada
Clearmind Medicine advances CMND-100 to dosing phase at Hadassah Medical Center - marketscreener.com
Clearmind Medicine Advances CMND-100 to Dosing Phase at Hadassah Medical Center in Ongoing Phase I/IIa Clinical Trial for Alcohol Use Disorder - The Manila Times
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Clearmind Medicine (CMND) Stock Analysis Report | Financials & Insights - Benzinga
Clearmind reports positive results in alcohol disorder treatment trial By Investing.com - Investing.com Nigeria
Clearmind reports positive results in alcohol disorder treatment trial - Investing.com
Clearmind Medicine Inc. Reports Key Milestones in Phase I/IIa Trial for Alcohol Use Disorder Treatment CMND-100 - Quiver Quantitative
Clearmind Medicine Inc (CMND) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.36%
1.05%
자본화:
|
볼륨(24시간):